Vitamin K in neonates: How to administer, when and to whom

Paediatric Drugs

Volumn 3, Issue 1, 2001, Pages 1-8

  Autret Leca, E ^a   Jonville Bera A P ^a  

^a CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; VITAMIN K GROUP;

ARTIFICIAL MILK; BLEEDING; BREAST FEEDING; BREAST MILK; CANCER RISK; HUMAN; LYMPHATIC LEUKEMIA; NEWBORN; PRACTICE GUIDELINE; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; VITAMIN K DEFICIENCY;

EID: 0035150597     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200103010-00001     Document Type: Review

References (68)

1. Current concepts and controversies in the use of vitamin K
2. Vitamin K deficiency bleeding (VKDB) in infancy
3. Haemorrhagic disease of the newborn returns
4. Neonatal vitamine K prophylaxis: Report of scientific and standardisation subcommittee on perinatal haemostasis
5. Plasma concentrations after oral or intramuscular vitamine K1 in neonates
6. Vitamin K1 concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone
7. Elimination half-life of vitamin K1 in neonates in longer than is generally assumed: Implications for the prophylaxis of haemorrhagic disease of the newborn
8. Effects of oral and intra muscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants
9. Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants
10. Vitamin K in infancy
11. Oral versus intramuscular vitamin K in newborn infants
12. Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom
13. Comparison of oral and parenteral vitamin K prophylaxis for prevention of late hemorrhagic disease of the newborn
14. Haemorrhagic disease of the newborn in the British Isles: Two year prospective study
15. Late haemothorax after oral vitamin K
16. Repeated oral vitamin K prophylaxis in West Germany: Acceptance and efficacy
17. Late haemorrhagic disease in Sweden 1987-89
18. Prevention of vitamin K deficiency bleeding: Efficacy of different multiple oral dose schedules of vitamin K
19. Weniger späte Vitamin-K-mangelblutungen
20. Neonatal vitamin K prophylaxis in Denmark: Three years experience with oral administration during the first three months of life compared with one oral administration at birth
21. The efficacy of oral vitamin K1: Implications for future prophylaxis to prevent haemorrhagic disease of the newborn?
22. Relationship of milk intake and vitamin K supplementation to vitamin K status in newborns
23. Compliance with recommendations for giving vitamin K to newborn infants
24. Does intramuscular vitamin K1 act as an unintended depot preparation?
25. Factors associated with childhood cancer in a national cohort study
26. Childhood cancer, intramuscular vitamin K, and pethidine given during labour
27. Administration of vitamin K to newborn infants and childhood cancer
28. The risk of childhood cancer after neonatal exposure to vitamin K
29. Childhood leukaemia and intramuscular vitamin K: Findings from a case-control study
30. Vitamin K and childhood cancer: A population based case-control study in Lower Saxony, Germany
31. Case-control study of childhood leukaemia and cancer in Scotland: Findings for neonatal intramuscular vitamin K
32. Ecological studies of relation between hospital policies on neonatal vitamin K administration and subsequent occurrence of childhood cancer
33. Neonatal vitamin K administration and childhood cancer in the north of England: Retro-spective case-control study
34. Case-control studies of relation between childhood cancer and neonatal vitamin K administration
35. Neonatal vitamin K prophylaxis: The Gordian knot still awaits untying
36. Screening for late neonatal vitamin K deficiency by carboxyprothrombin in dried blood spots
37. PIVKA-II levels after prophylactic vitamin K
38. Vitamin K1 levels and coagulation factors in healthy term newborns fill 4 weeks after birth
39. Vitamin K status of lactating mothers, human milk, and breast-feeding infants
40. Oral vitamin K prophylaxis for newborn infants: Safe enough?
41. Vitamin K deficiency in breastfed infants at one month of age
42. The use of vitamin K in the perinatal period
43. Oral vitamin K prophylaxis and frequency of late vitamin K deficiency bleeding
44. Oral vitamine K in breast-fed infants to prevent late haemorrhagic disease of the newborn
45. Evaluation of a daily dose of 25 μg vitamin K1 to prevent vitamin K deficiency in breast-fed infants
46. Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K
47. Neonatal vitamin K prophylaxis in Denmark: Three years' experience with oral administration during the first three months of life compared with one oral administration at birth
48. Vitamin K for neonates
49. Placental transfer of vitamin K1 in preterm pregnancy
50. Vitamin K-dependent clotting factors during long-term total parenteral nutrition in full-term and preterm infants
51. Serum vitamin K1 concentrations after oral administration of vitamin K1 in low birth weight infants
52. A review of vitamine K, epilepsy and pregnancy
53. PIVKA-II (protein induced by vitamine K absence-II) status in newborns exposed to anticonvulsant drugs in utero
54. Oral supplementation of vitamin K for pregnant women and effects on levels of plasma vitamin K and PIVKA-II in the neonate
55. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency
56. Use of vitamin K1 in pregnancy
57. Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother
58. Epilepsy and pregnancy
59. Oral versus intramuscular phytomenadione
60. Prevention of vitamin K deficiency bleeding in newborns
61. Plasma vitamin K1 and PIVKA-II after oral administration of mixed-micellar or cremophor EL-solubilized preparations of vitamin K1 to normal breast-fed newborns
62. Pharmacokinetics and safety of a new solution of vitamin K1 (20) in children with cholestasis
63. Modalités utilisation de la vitamine Ken France chez le nouveau-né
64. La vitamine Ken pédiatrie. Recommandations de prescriptions
65. Vitamin K administration in the newborn: Statement by fetus and newborn committee of Paediatric Society of New Zealand
66. Joint statement and interim recommendations on vitamin K prophylaxis for haemorrhagic disease in infancy
67. Controversies concerning vitamin K and the newborn
68. Vitamin K prophylaxis in the newborn - Again